MilliporeSigma

February 4, 2019
Categories

Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment

[vc_row][vc_column][vc_column_text] Cell and gene therapies (CGTs) offer an unprecedented opportunity to treat diseases for which existing interventions are inadequate, potentially offering cures for previously terminal illnesses. […]
Do you like it?
Read more
January 23, 2018
Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?
Categories

Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?

[vc_row][vc_column][vc_column_text]The Food and Drug Administration recently announced the first ever approval of a directly administered gene therapy in the United States. Spark Therapeutics one-time gene therapy […]
Do you like it?
Read more
June 20, 2016
Texcell acquisition of Vivo Science underscores the shifting Biopharma Contract Services landscape
Categories

Texcell acquisition of Vivo Science underscores the shifting Biopharma Contract Services landscape

Texcell, a French provider of biosafety contract services, recently acquired German company Vivo Science GmbH, a GLP/GMP compliant contract research test facility specialising in toxicology, immunology […]
Do you like it?
Read more